Top Buy
Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▼ | Target price | Potential |
---|---|---|---|---|---|---|---|
Astellas Pharma Inc. | 1 | 0 | 0 | 0 | €10.23 | - | - |
Eli Lilly Corp. | 62 | 1 | 7 | 1 | €752.50 | €824.47 | 9.564% |
Sanofi S.A. ADR | 9 | 0 | 0 | 0 | €48.20 | - | - |
Esperion Therapeutis.Inc. | 17 | 1 | 3 | 0 | €2.27 | €8.55 | 275.792% |
MorphoSys AG | 7 | 0 | 0 | 0 | €67.80 | €65.00 | -4.130% |
Dr. Reddy's Laboratories Ltd. ADR | 6 | 1 | 0 | 0 | €74.00 | €74.65 | 0.872% |
Emergent Biosolutions Inc. | 4 | 3 | 1 | 0 | €12.65 | - | - |
Eledon Pharmaceuticals Inc. | 6 | 0 | 0 | 0 | €2.88 | €12.21 | 323.990% |
AstraZeneca plc | 2 | 0 | 0 | 0 | €144.40 | €165.00 | 14.266% |
Veracyte Inc. | 1 | 0 | 0 | 0 | €22.00 | - | - |
Bayer AG | 16 | 3 | 3 | 2 | €27.30 | €45.00 | 64.865% |
Knight Therapeutics | 1 | 0 | 0 | 0 | €3.72 | €10.00 | 168.817% |
Adverum Biotechnologies Inc. | 9 | 0 | 1 | 0 | €1.38 | €20.55 | 1388.986% |
ProQR Therapeutics N.V. | 8 | 2 | 0 | 0 | €1.73 | €3.03 | 75.399% |
Xenon Pharmaceuticals Inc. | 1 | 1 | 0 | 0 | €40.60 | €50.00 | 23.153% |
Rhythm Pharmaceuticals | 16 | 0 | 1 | 0 | €45.60 | €46.37 | 1.689% |
Nektar Therapeutics | 4 | 1 | 1 | 0 | €1.26 | €2.40 | 90.627% |
Merck & Co. Inc. | 30 | 1 | 0 | 0 | €115.80 | €124.97 | 7.922% |
Catalyst Pharmaceutical Partners Inc | 13 | 0 | 0 | 0 | €16.00 | €24.44 | 52.721% |
Novo Nordisk A/S | 5 | 0 | 1 | 0 | €185.00 | €195.00 | 5.405% |
Trinity Biotech ADR | 27 | 0 | 3 | 0 | €0.41 | - | - |
Immutep LTD ADR | 1 | 0 | 0 | 0 | €1.97 | €4.00 | 103.046% |
Verastem Inc. | 12 | 0 | 2 | 0 | €2.74 | €17.56 | 540.730% |
Xeris Biopharma Holdings Inc. | 6 | 0 | 0 | 0 | €2.36 | €4.39 | 86.388% |
Abbott Laboratories | 19 | 0 | 1 | 0 | €97.11 | €116.25 | 19.707% |